Nanosomal Docetaxel Lipid Suspension
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Nanosomal Docetaxel Lipid Suspension, covering 2017-04-11 to 2025-03-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients [Phase 3]